Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass., March 26, 2022 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing SINTAX™ medicines…
Late-breaking Phase 3 data at AAD 2022 show Dupixent® (dupilumab) significantly improved signs and symptoms of prurigo nodularis Dupixent significantly…
PHILADELPHIA, March 26, 2022 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a…
REDWOOD CITY, Calif., March 25, 2022 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on…
Leuven, BELGIUM, Boston, MA, US – March 25, 2022 – 09.00 PM CET – Oxurion NV (Euronext Brussels: OXUR) (the…
SAN DIEGO, March 25, 2022 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage company focused on developing potential first-in-class…
SAN FRANCISCO, March 25, 2022 (GLOBE NEWSWIRE) — GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced…
SAN DIEGO, March 25, 2022 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery…
Company Sets New Quarterly Record for Number of Individual E-Commerce Order Transactions New York, NY, March 25, 2022 (GLOBE NEWSWIRE)…
BOSTON, March 25, 2022 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a biopharmaceutical company committed to defeating cancer using RNA…